A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that while traditional pathological features used to classify aggressive prostate cancer—such as high-grade disease, cancer extending ...
Aug 10, 2026
0
347
Researchers at the University of Colorado Anschutz Cancer Center have identified a previously unknown metabolic weakness in the stem cells that drive high-risk myelodysplastic syndromes (MDS), a discovery that could lead ...
Aug 10, 2026
0
7
A tumor is more than its cancer cells. Immune cells, blood vessels and other surrounding tissue influence how a cancer grows and responds to treatment. Two tumors containing the same cell types can respond very differently ...
Aug 10, 2026
0
7
A team led by researchers from the German Cancer Research Center (DKFZ), the HI-STEM Stem Cell Institute, and Medical Clinic V at Heidelberg University Hospital (UKHD) has characterized T cells in the bone marrow of patients ...
Aug 10, 2026
0
6
Replacing 15 minutes of sleep or sedentary behavior with 15 minutes of movement was each linked to a 2% reduced risk of cancer, new UCL research has found.
Aug 10, 2026
0
11
Scientists from St. Jude Children's Research Hospital and collaborators have discovered that the RNA-binding protein MBNL1 promotes the growth of a form of childhood leukemia characterized by KMT2A gene rearrangements. The ...
Aug 10, 2026
0
5
Researchers at Tel Aviv University have developed a new method for diagnosing lung cancer: a simple, fast, low-cost blood test that does not require DNA sequencing. The method identifies a chemical fingerprint of cancer cells ...
Aug 10, 2026
0
46
Liver cancer experts at the Johns Hopkins Kimmel Cancer Center and 16 other cancer centers have compiled new guidance on the best treatments for hepatocellular carcinoma (HCC) in North America. The resource, called BEACON-HCC, ...
Aug 10, 2026
0
1
Researchers at UC San Francisco have developed a new method to predict how different types of breast cancer will respond to treatment, using patient data from the I-SPY2 breast cancer trial and rapid testing on lab-grown ...
Aug 10, 2026
0
14
The cost-effectiveness of the immunotherapy drug pembrolizumab for patients with locally advanced head and neck squamous cell carcinoma may depend on biomarker results, according to a new study.
Aug 10, 2026
0
3
